{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:52:45Z","timestamp":1785898365179,"version":"3.56.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.reprotox.2020.10.011","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T04:29:30Z","timestamp":1604291370000},"page":"286-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Focus on germ-layer markers: A human stem cell-based model for in vitro teratogenicity testing"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-9615","authenticated-orcid":false,"given":"Manuela","family":"Jaklin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3085-0909","authenticated-orcid":false,"given":"Jitao David","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4641-1318","authenticated-orcid":false,"given":"Paul","family":"Barrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Clemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Leist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kustermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2020.10.011_bib0005","series-title":"ICH Harmonized Guideline Detection Of Reproductive And Developmental Toxicity For Human Pharmaceuticals S5(R3)","author":"ICH","year":"2020"},{"issue":"3","key":"10.1016\/j.reprotox.2020.10.011_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.14573\/altex.1406091","article-title":"Consensus report on the future of animal-free systemic toxicity testing","volume":"31","author":"Leist","year":"2014","journal-title":"Altex"},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ilar\/ilw026","article-title":"Alternative models of developmental and reproductive toxicity in pharmaceutical risk assessment and the 3Rs","volume":"57","author":"Brannen","year":"2016","journal-title":"ILAR J."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0020","series-title":"Teratogenicity Testing: Methods and Protocols","first-page":"423","article-title":"The rat whole embryo culture assay using the dysmorphology score system","author":"Zhang","year":"2013"},{"key":"10.1016\/j.reprotox.2020.10.011_bib0025","series-title":"Ed.), Teratogenicity Testing: Methods and Protocols","article-title":"Zebrafish teratogenicity testing","author":"Brannen","year":"2013"},{"key":"10.1016\/j.reprotox.2020.10.011_bib0030","series-title":"Teratogenicity Testing: Methods and Protocols","first-page":"375","article-title":"The embryonic stem cell test","author":"Schulpen","year":"2013"},{"issue":"4","key":"10.1016\/j.reprotox.2020.10.011_bib0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/bdrb.21078","article-title":"Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening","volume":"98","author":"Palmer","year":"2013","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.reprotox.2017.07.011","article-title":"A human induced pluripotent stem cell-based in vitro assay predicts developmental toxicity through a retinoic acid receptor-mediated pathway for a series of related retinoid analogues","volume":"73","author":"Palmer","year":"2017","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0045","article-title":"Profiling the ToxCast library with a pluripotent human (H9) stem cell line-based biomarker assay for developmental toxicity","author":"Zurlinden","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"30","key":"10.1016\/j.reprotox.2020.10.011_bib0050","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.2174\/0929867323666160627113436","article-title":"Human embryonic and induced pluripotent stem cell based toxicity testing models: future applications in new drug discovery","volume":"23","author":"Shinde","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0055","first-page":"3","article-title":"The embryonic stem cell test for the early selection of pharmaceutical compounds","volume":"24","author":"Whitlow","year":"2007","journal-title":"ALTEX-Altern. Anim. Experiment."},{"issue":"3","key":"10.1016\/j.reprotox.2020.10.011_bib0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/026119290403200305","article-title":"Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests","volume":"32","author":"Genschow","year":"2004","journal-title":"Altern. Lab. Anim."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/toxsci\/kft239","article-title":"A high-throughput screen for teratogens using human pluripotent stem cells","volume":"137","author":"Kameoka","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00204-012-0967-3","article-title":"Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach","volume":"87","author":"Krug","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0075","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00204-016-1741-8","article-title":"Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests","volume":"91","author":"Shinde","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.reprotox.2020.10.011_bib0080","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00204-013-1154-x","article-title":"Test systems of developmental toxicity: state-of-the art and future perspectives","volume":"87","author":"Leist","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0085","series-title":"Teratogenicity Testing: Methods and Protocols","first-page":"451","article-title":"Toxicogenomic approaches in developmental toxicology testing","author":"Robinson","year":"2013"},{"issue":"9","key":"10.1016\/j.reprotox.2020.10.011_bib0090","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00204-015-1573-y","article-title":"A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors","volume":"89","author":"Rempel","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00204-019-02612-5","article-title":"Development of a neural rosette formation assay (RoFA) to identify neurodevelopmental toxicants and to characterize their transcriptome disturbances","volume":"94","author":"Dreser","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"15","key":"10.1016\/j.reprotox.2020.10.011_bib0100","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/bdr2.1746","article-title":"Teratogen?","volume":"112","author":"Scialli","year":"2020","journal-title":"Birth Defects Res."},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/026119290203000205","article-title":"Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests","volume":"30","author":"Brown","year":"2002","journal-title":"Eur. Centre Validation Alternative Methods Alternatives Lab. animals: ATLA"},{"issue":"6","key":"10.1016\/j.reprotox.2020.10.011_bib0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bdrb.21132","article-title":"Exposure-based validation list for developmental toxicity screening assays","volume":"101","author":"Daston","year":"2014","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-62703-131-8_24","article-title":"Maternal toxicity","volume":"947","author":"Danielsson","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.reprotox.2020.10.011_bib0120","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/nbt.3387","article-title":"A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells","volume":"33","author":"Tsankov","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"7539","key":"10.1016\/j.reprotox.2020.10.011_bib0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature14233","article-title":"Transcription factor binding dynamics during human ES cell differentiation","volume":"518","author":"Tsankov","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.reprotox.2020.10.011_bib0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cell.2010.12.032","article-title":"Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines","volume":"144","author":"Bock","year":"2011","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.reprotox.2020.10.011_bib0135","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrg3271","article-title":"Genetic and epigenetic stability of human pluripotent stem cells","volume":"13","author":"Lund","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.reprotox.2020.10.011_bib0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.scr.2012.06.008","article-title":"High-throughput karyotyping of human pluripotent stem cells","volume":"9","author":"Lund","year":"2012","journal-title":"Stem Cell Res."},{"issue":"5928","key":"10.1016\/j.reprotox.2020.10.011_bib0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"issue":"5858","key":"10.1016\/j.reprotox.2020.10.011_bib0150","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.reprotox.2020.10.011_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022174","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study","volume":"6","author":"van Gelder","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0041-008X(69)90032-5","article-title":"Absorption, distribution and toxicity of ibuprofen","volume":"15","author":"Adams","year":"1969","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"10.1016\/j.reprotox.2020.10.011_bib0165","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/dmcn.12745","article-title":"Use of paracetamol during pregnancy and child neurological development","volume":"57","author":"de Fays","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.reprotox.2020.10.011_bib0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","article-title":"Nonsteroidal anti-inflammatory drugs in early pregnancy","volume":"15","author":"Ericson","year":"2001","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/humrep\/det370","article-title":"Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks","volume":"29","author":"van Gelder","year":"2013","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0180","first-page":"25","article-title":"Treating pain during pregnancy","volume":"56","author":"Babb","year":"2010","journal-title":"Can. Fam. Physician"},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00228-017-2351-y","article-title":"Drug safety in pregnancy: the German Embryotox institute","volume":"74","author":"Dathe","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.reprotox.2020.10.011_bib0190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/tera.1420350319","article-title":"Valproic acid","volume":"35","author":"Lammer","year":"1987","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2020.10.011_bib0195","doi-asserted-by":"crossref","DOI":"10.1093\/biohorizons\/hzt003","article-title":"A scientific review: mechanisms of valproate-mediated teratogenesis","volume":"6","author":"Lloyd","year":"2013","journal-title":"Biosci. Horiz."},{"issue":"Suppl 1","key":"10.1016\/j.reprotox.2020.10.011_bib0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000211162","article-title":"Embryotoxicity and teratogenicity of topical retinoic acid","volume":"6","author":"Nau","year":"1993","journal-title":"Skin Pharmacol."},{"issue":"14","key":"10.1016\/j.reprotox.2020.10.011_bib0205","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0210","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/978-94-011-6621-8_29","article-title":"Foetal malformations due to thalidomide","author":"Lenz","year":"1962","journal-title":"Problems Birth Defects"},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1753193418805249","article-title":"The teratogenic effects of thalidomide on limbs","volume":"44","author":"Vargesson","year":"2019","journal-title":"J. Hand Surg. Eur. Vol."},{"issue":"5305","key":"10.1016\/j.reprotox.2020.10.011_bib0220","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bmj.2.5305.646","article-title":"Thalidomide and congenital abnormalities","volume":"2","author":"Ward","year":"1962","journal-title":"Br. Med. J."},{"issue":"1358","key":"10.1016\/j.reprotox.2020.10.011_bib0225","first-page":"90927","article-title":"Thalidomide and congenital abnormalities","volume":"2","author":"McBride","year":"1961","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.reprotox.2020.10.011_bib0230","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0022-3476(68)80430-5","article-title":"Methotrexate-induced congenital malformations: with a review of the literature","volume":"72","author":"Milunsky","year":"1968","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.reprotox.2020.10.011_bib0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update: methotrexate","volume":"94","author":"Hyoun","year":"2012","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"issue":"7","key":"10.1016\/j.reprotox.2020.10.011_bib0240","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ajmg.a.34037","article-title":"Methotrexate and misoprostol teratogenicity: further expansion of the clinical manifestations","volume":"155a","author":"Kozma","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"issue":"8","key":"10.1016\/j.reprotox.2020.10.011_bib0245","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/sj.leu.2402168","article-title":"Exposure to hydroxyurea during pregnancy: a case series","volume":"15","author":"Thauvin-Robinet","year":"2001","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.reprotox.2020.10.011_bib0250","first-page":"1046","article-title":"Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia","volume":"101","author":"Ballas","year":"2009","journal-title":"J. Med. Assoc."},{"issue":"5","key":"10.1016\/j.reprotox.2020.10.011_bib0255","first-page":"1135","article-title":"Prevalence and incidence of congenital anomalies amongst babies born to women with sickle cell disease and exposed to hydroxyurea during pregnancy: a systematic review protocol","volume":"16","author":"Gwer","year":"2018","journal-title":"JBI Evid. Synthesis"},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<148::AID-AJH12>3.0.CO;2-I","article-title":"Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature","volume":"60","author":"Diav-Citrin","year":"1999","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/jn\/62.2.201","article-title":"The Vanderbilt cooperative study of maternal and infant nutrition. X. Ascorbic acid","volume":"62","author":"Martin","year":"1957","journal-title":"J. Nutr."},{"issue":"7","key":"10.1016\/j.reprotox.2020.10.011_bib0270","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/1933719110368870","article-title":"The impact of vitamin C supplementation in pregnancy and in vitro upon fetal membrane strength and remodeling","volume":"17","author":"Mercer","year":"2010","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0275","first-page":"9","article-title":"Vitamin C supplementation in pregnancy","author":"Rumbold","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/inf.1970.2.issue-2.09","article-title":"Transplacental passage of Azidocillin, ampicillin and penicillin G during early and late pregnancy","volume":"2","author":"Wasz-H\u00f6ckert","year":"1970","journal-title":"Scand. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.reprotox.2020.10.011_bib0285","first-page":"919","article-title":"Teratogenicity of antibacterial agents","volume":"32","author":"Eri\u0107","year":"2008","journal-title":"Coll. Antropol."},{"issue":"5","key":"10.1016\/j.reprotox.2020.10.011_bib0290","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/01.AOG.0000216197.26783.b5","article-title":"Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks","volume":"107","author":"Nahum","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01660412","article-title":"Antibiotics in pregnancy: toxicity and teratogenicity","volume":"13","author":"Knothe","year":"1985","journal-title":"Infection"},{"key":"10.1016\/j.reprotox.2020.10.011_bib0300","series-title":"ddCt: The ddCt Algorithm for the Analysis of Quantitative Real-time PCR (qRT-PCR), R Package Version 1.20.0","author":"Zhang","year":"2010"},{"issue":"4","key":"10.1016\/j.reprotox.2020.10.011_bib0305","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"7","key":"10.1016\/j.reprotox.2020.10.011_bib0310","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.reprotox.2020.10.011_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JMI.4.4.044003","article-title":"Method for evaluation of human induced pluripotent stem cell quality using image analysis based on the biological morphology of cells","volume":"4","author":"Wakui","year":"2017","journal-title":"J. Med. Imaging"},{"issue":"9","key":"10.1016\/j.reprotox.2020.10.011_bib0320","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nmeth.3507","article-title":"Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells","volume":"12","author":"Paull","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.reprotox.2020.10.011_bib0325","series-title":"Stem Cells","first-page":"21","article-title":"Embryonic Stem Cell-Derived Embryoid Bodies: An In Vitro Model of Eutherian Pregastrulation Development and Early Gastrulation","author":"Weitzer","year":"2006"},{"issue":"100","key":"10.1016\/j.reprotox.2020.10.011_bib0330","doi-asserted-by":"crossref","DOI":"10.3791\/52333","article-title":"Human pluripotent stem cell based developmental toxicity assays for chemical safety screening and systems biology data generation","author":"Shinde","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0335","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13287-016-0449-2","article-title":"Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cells","volume":"7","author":"Shinde","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0340","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.reprotox.2019.10.004","article-title":"Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells","volume":"91","author":"Marikawa","year":"2020","journal-title":"Reprod. Toxicol."},{"issue":"19","key":"10.1016\/j.reprotox.2020.10.011_bib0345","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1242\/dev.052753","article-title":"A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency","volume":"137","author":"Guo","year":"2010","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0350","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.stem.2009.12.009","article-title":"The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells","volume":"6","author":"Heng","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reprotox.2020.10.011_bib0355","article-title":"The combined action of Esrrb and Nr5a2 is essential for na\u00efve pluripotency","author":"Festuccia","year":"2020","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.reprotox.2020.10.011_bib0360","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1007\/s00204-018-2326-5","article-title":"Major changes of cell function and toxicant sensitivity in cultured cells undergoing mild, quasi-natural genetic drift","volume":"92","author":"Gutbier","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0365","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/jpet.104.067793","article-title":"Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans","volume":"310","author":"Lu","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0370","doi-asserted-by":"crossref","first-page":"21419","DOI":"10.1038\/srep21419","article-title":"Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model","volume":"6","author":"Kazuki","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0375","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0380","doi-asserted-by":"crossref","first-page":"11413","DOI":"10.1038\/s41598-019-47739-8","article-title":"The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis","volume":"9","author":"Gomes","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.reprotox.2020.10.011_bib0385","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acs.chemrestox.6b00259","article-title":"Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity","volume":"30","author":"Waldmann","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2020.10.011_bib0390","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/tx400402j","article-title":"Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells","volume":"27","author":"Waldmann","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.reprotox.2020.10.011_bib0395","doi-asserted-by":"crossref","first-page":"682","DOI":"10.14573\/altex.1909271","article-title":"Template for the description of cell-based toxicological test methods to allow evaluation and regulatory use of the data","volume":"36","author":"Krebs","year":"2019","journal-title":"Altex"},{"key":"10.1016\/j.reprotox.2020.10.011_bib0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2016.03.048","article-title":"Revision of the ICH guideline on detection of toxicity to reproduction for medicinal products: SWOT analysis","volume":"64","author":"Barrow","year":"2016","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.reprotox.2020.10.011_bib0405","first-page":"49","article-title":"Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use","volume":"34","author":"Aschner","year":"2017","journal-title":"Altex"},{"issue":"3","key":"10.1016\/j.reprotox.2020.10.011_bib0410","doi-asserted-by":"crossref","first-page":"306","DOI":"10.14573\/altex.1712081","article-title":"Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicity","volume":"35","author":"Bal-Price","year":"2018","journal-title":"Altex"},{"issue":"6","key":"10.1016\/j.reprotox.2020.10.011_bib0415","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/bdrb.20276","article-title":"A different approach to validating screening assays for developmental toxicity","volume":"89","author":"Daston","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0420","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900294","article-title":"Microfluidic multitissue platform for advanced embryotoxicity testing in vitro","author":"Boos","year":"2019","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.reprotox.2020.10.011_bib0425","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF03401776","article-title":"Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers","volume":"6","author":"Itskovitz-Eldor","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0430","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-445X.2000.02104.x","article-title":"Embryoid bodies: an in vitro model ofmouse embryogenesis","author":"Desbaillets","year":"2000","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0435","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0578-0","article-title":"Multi-axial self-organization properties of mouse embryonic stem cells into gastruloids","author":"Beccari","year":"2018","journal-title":"Nature"},{"issue":"7812","key":"10.1016\/j.reprotox.2020.10.011_bib0440","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-020-2383-9","article-title":"An in vitro model of early anteroposterior organization during human development","volume":"582","author":"Moris","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.reprotox.2020.10.011_bib0445","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nmeth.3016","article-title":"A method to recapitulate early embryonic spatial patterning in human embryonic stem cells","volume":"11","author":"Warmflash","year":"2014","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.reprotox.2020.10.011_bib0450","doi-asserted-by":"crossref","first-page":"e1222","DOI":"10.1038\/cddis.2014.166","article-title":"Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP+","volume":"5","author":"Krug","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.reprotox.2020.10.011_bib0455","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-020-02656-y","article-title":"Prospects and challenges of multi-omics data integration in toxicology","author":"Canzler","year":"2020","journal-title":"Arch. Toxicol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623820302379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623820302379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:53:46Z","timestamp":1760190826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623820302379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":91,"alternative-id":["S0890623820302379"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2020.10.011","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focus on germ-layer markers: A human stem cell-based model for in vitro teratogenicity testing","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2020.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 F. Hoffmann - La Roche Ltd. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}